Food and Drug Administration is investigating a possible link between
Merck's best-selling Singulair and suicide. FDA said it is reviewing a
handful of reports involving mood changes, suicidal behavior and suicide
in patients who have taken the popular allergy and asthma drug.
http://www.elpasotimes.com/health/ci_8715975
Powered by LSoft's LISTSERV(R) list management software